Toshiba America Medical Systems | Leading Innovation

Non-Contrast MR Angiography

Based on a growing body of evidence that links gadolinium-based contrast agents with Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy (NSF/NFD), there is a clear need for rapid, ultra-clear MRA without the use of contrast agents.

In 1998, Toshiba pioneered non-contrast MR imaging. Now, with over 10 years of clinical experience, Toshiba's Vantage systems are the only systems available with a complete suite of contrast-free MRA techniques.

TSA: Time Space Angiography

Second generation of Time-SLIP and fourth generation of non-contrast techniques. This Time-SLIP based technique, utilizes variable BB-T1 times to create non-contrast time-resolved imaging with high temporal resolution and useful for imaging blood flow in the head and neck. View example »

FBI: Fresh Blood Imaging

With exceptional sensitivity to slow flow, FBI is particularly well-suited for evaluating peripheral vascular diseases of the lower legs and extremities. It acquires arterial and venous flow in a single coronal pass requiring less scan time than other MRA techniques. FBI also eliminates sensitivity to issues like improper timing, turbulent flow and differential filling that can cause contrast-based MRA to fail. View example »

CIA: Contrast-Free Improved Angiography

CIA is the latest generation of contrast-free applications with easier acquisition and superior imaging of smaller vessels. This technique adds systolic black blood imaging to reduce ghosting and improve arterial and venous flow separation. CIA expands the window of opportunity for evaluating early disease states. View example »

Time-SLIP: Spatial Labeling Inversion Pulse

Time-SLIP is useful for evaluating hemodynamic velocity, functional assessments, and visualization of vascular structures. It reveals regions excited as bright or black blood and can be used with FASE or TRUESSFP sequences in gated, two- and three-dimensional acquisitions. View example »

Need more information? Click here!

Patient Risk & Gadolinium

  • NSF/NFD is a rare disease causing fibrosis of the skin and connective tissue throughout the body and has been associated with patients who had previously received gadolinium based contrast agents.
  • The FDA issued an alert urging caution with regard to the use of gadolinium-based contrast agents.
  • NSF/NFD is a progressive disease that can develop rapidly and often proves fatal.

Discover the latest clinical advancements in Cardiac and Neurovascular CTA, and Non-contrast MRA Review clinical case studies demonstrating Sure Subtraction, Sure Plaque and non-contrast techniques. Click here »

Non-Contrast Vascular Imaging in Everyday Clinical Use

Presentation by: Timothy Albert, MD, FACC, Medical Director, Cardiovascular Diagnostic Center, Salinas Valley Memorial Hospital. Watch video now »

 
 

Terms & Conditions | Privacy Policy © 2009 Toshiba Corporation